Hereditary amyloid cardiomyopathy caused by a variant apolipoprotein A1

American Journal of Pathology

Volumn 154, Issue 1, 1999, Pages 221-227

  Hamidi Asl, Ladan ^a   Liepnieks, Juris J ^b,c   Hamidi Asl, Kamran ^b   Uemichi, Tomoyuki ^b   Moulin, Georges ^d   Desjoyaux, Emmanuel ^f   Loire, Robert ^e   Delpech, Marc ^a   Grateau, Gilles ^g   Benson, Merrill D ^b,c  

^a Lab de Biochim et Biol Molec ^*  (France)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Richard L Roudeboush Vet Aff M   (United States)

^d Hopital de l'Antiquaille   (France)

^e LOUIS PRADEL HOSPITAL   (France)

^f Centre Hospitalier de la Region d'Annecy   (France)

^g HÔTEL DIEU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; AMYLOID; APOLIPOPROTEIN A1; PROTEIN PRECURSOR;

ARTICLE; AUTOSOMAL DOMINANT DISORDER; CARBOXY TERMINAL SEQUENCE; CASE REPORT; CLINICAL FEATURE; CONTROLLED STUDY; EXON; FEMALE; HEART AMYLOIDOSIS; HUMAN; HUMAN CELL; MALE; NUCLEIC ACID BASE SUBSTITUTION; POINT MUTATION; PRIORITY JOURNAL; PROTEIN STRUCTURE; PROTEIN VARIANT; STRUCTURE ANALYSIS;

EID: 0010287190     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65268-6     Document Type: Article

References (39)

1. Benson MD: Amyloidosis. The Metabolic Basis of Inherited Disease, ed 7. Edited by Scriver CR, Beaudet AL, Sly WS, Valle D, New York, McGraw-Hill, 1995, pp 4159-4191
2. Goate A, Chartier-Harlin M-C, Mullan M, Brown J, Crawford F, Fidani L, Giuffra L, Haynes A, Irving N, James R, Mant R, Newton P, Rooke K, Roques P, Talbot C, Pericak-Vance M, Roses A, Williamson R, Rossor M, Owen M, Hardy J: Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 1991, 349:704-706
3. Murrell J, Farlow M, Ghetti B, Benson MD: A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease Science 1991, 254:97-99
4. Sletten K, Westermark P, Natvig JB: Characterization of amyloid fibril proteins from medullary carcinoma of the thyroid. J Exp Med 1976, 143:993-998
5. Benson MD, Uemichi T: Transthyretin amyloidosis. Amyloid 1996, 3:44-51
6. Levy E, Haltia M, Fernandez-Madrid I, Koivunen O, Ghiso J, Prelli F, Frangione B: Mutation in gelsolin gene in Finnish hereditary amyloidosis. J Exp Med 1990, 172:1865-1867
7. Nichols WC, Gregg RE, Brewer HB Jr, Benson MD: A mutation in apolipoprotein A-I in the Iowa type of familial amyloidotic polyneuropathy. Genomics 1990, 8:318-323
8. Benson MD, Liepnieks J, Uemichi T, Wheeler G, Correa R: Hereditary renal amyloidosis associated with a mutant fibrinogen α-chain. Nature Genet 1993, 3:252-255
9. Pepys MB, Hawkins PN, Booth DR, Vigushin DM, Tennent GA, Soutar AK, Totty N, Nguyen O, Blake CC, Terry CJ, Feest TG, Zalin AM, Hsuan JJ: Human lysozyme gene mutations cause hereditary systemic amyloidosis. Nature 1993, 362:553-557
10. Ghiso J, Pons-Estel B, Frangione B: Hereditary cerebral amyloid angiopathy: the amyloid fibrils contain a protein which is a variant of cystatin C, an inhibitor of lysosomal cysteine proteases. Biochem Biophys Res Commun 1986, 136:548-554
11. Van Allen M, Frohlich J, Davis J: Inherited predisposition to generalized amyloidosis. Neurology 1969, 19:10-25
12. Vigushin DM, Gough J, Allan D, Alguacil A, Penner B, Pettigrew NM, Quinonez G, Bernstein K, Booth SE, Booth DR, Soutar AK, Hawkins PN, Pepys MB: Familial nephropathic systemic amyloidosis caused by apolipoprotein AI variant Arg26. Q J Med 1994, 87:149-154
13. Booth DR, Tan SY, Booth SE, Tennent GA, Hutchinson WL, Hsuan JJ, Totty NF, Truong O, Soutar AK, Hawkins PN, Bruguera M, Caballeria J, Sole M, Campistol JM, Pepys MB: Hereditary hepatic and systemic amyloidosis caused by a new deletion/insertion mutation in the apolipoprotein AI gene. J Clin Invest 1996, 97:2714-2721
14. l 1988, 115:565-570
15. Pras M, Schubert M, Zucker-Franklin D, Rimon A, Franklin EC: The characterization of soluble amyloid prepared in water. J Clin Invest 1968, 47:924-933
16. Hamidi Asl K, Liepnieks JJ, Bihrle R, Benson MD: Local synthesis of amyloid fibril precursor in AL amyloidosis of the urinary tract. Amyloid 1998, 5 49-54
17. Schagger H, Von Jagow G: Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1-100 kDa. Anal Biochem 1987, 166:368-379
18. Sambrook J, Fritsch EF, Maniatis J: Molecular Cloning: A Laboratory Manual, ed 2. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory Press, 1989
19. Seilhamer JJ, Protter AA, Frossard P, Levy-Wilson B: Isolation and DNA sequence of full-length cDNA and of the entire gene for human apolipoprotein AI: discovery of a new genetic polymorphism in the apo AI gene. DNA 1984, 3:309-317
20. Olsen KE, Sandgren O, Sletten K, Westermark P: Primary localized amyloidosis of the eyelid: two cases of immunoglobulin light chain-derived proteins, subtype lambda V respectively lambda VI. Clin Exp Immunol 1996, 106:362-366
21. Rubinow A, Cohen AS: Skin involvement in familial amyloidotic polyneuropathy. Neurology 1981, 31:1341-1345
22. Soutar KA, Hawkins PN, Vigushin DM, Tennent GA, Booth SE, Hutton T, Nguyen O, Totty NF, Feest TG, Hsuan JJ, Pepys MB: Apolipoprotein AI mutation Arg60 causes autosomal dominant amyloidosis. Proc Natl Acad Sci USA 1992, 89:7389-7393
23. Booth DR, Tan SY, Booth SE, Hsuan JJ, Totty NF, Nguyen O, Hutton T, Vigushin DM, Tennent GA, Hutchinson WL, Thomson N, Soutar AK, Hawkins PN, Pepys MB: A new apolipoprotein AI variant, Trp 50 Arg, causes hereditary amyloidosis. Q J Med 1995, 88:695-702
24. Persey MR, Booth DR, Booth SE, Van Zyl-Smit R, Adams BK, Fattaar AB, Tennent GA, Hawkins PN, Pepys MB: Hereditary nephropathic systemic amyloidosis caused by a novel variant apolipoprotein A-I. Kidney Int 1998, 53:276-281
25. Gorevic PD, Munoz PC, Gorgone G: Amyloidosis due to a mutation of the gelsolin gene in an American family with lattice corneal dystrophy type II. N Engl J Med 1991, 325:1780-1785
26. Benedikz E, Blšndal H, Gudmundsson G: Skin deposits in hereditary cystatin C amyloidosis. Virchows Arch A (Pathol Anat) 1990, 417:325-331
27. Wang WJ: Clinical features of cutaneous amyloidosis. Clin Dermatol 1990, 8:13-19
28. Vasily DB, Bhatia SG, Uhlin SR: Familial primary cutaneous amyloidosis, clinical, genetic, and immunofluorescent studies. Arch Dermatol 1978, 114:1173-1176
29. Newton JA, Jagjvan A, Bhogal B, McKee PH, McGibbon DH: Familial primary cutaneous amyloidosis. Br J Dermatol 1985, 112:201-208
30. Rajagopalan K, Tay CH: Familial lichen amyloidosis: report of 19 cases in 4 generations of a chinese family in Malaysia. Br J Dermatol 1972, 87:123-129
31. Johnson KH, Sletten K, Hayden DW, O'Brien TD, Roertgen KE, Westermark P: Pulmonary vascular amyloidosis in aged dogs: a new form of spontaneously occurring amyloidosis derived from apolipoprotein A1. Am J Pathol 1992, 141:1013-1019
32. Westermark P, Mucchiano G, Marthin T, Johnson KH, Sletten K: Apolipoprotein AI-derived amyloid in human aortic atherosclerotic plaques. Am J Pathol 1995, 147:1186-1192
33. Westermark P, Sletten K, Johansson B, Cornwell GG: Fibril in senile systemic amyloidosis is derived from normal transthyretin. Proc Natl Acad Sci USA 1990, 87:2843-2845
34. Hamilton JA, Steinrauf LK, Braden BC, Liepnieks J, Benson MD, Holmgren G, Sandgren O, Steen L: The x-ray crystal structure refinements of normal human transthyretin and the amyloidogenic Val30→Met variant to 1.7-Å resolution. J Biol Chem 1993, 268:2416-2424
35. Booth DR, Sunde M, Bellotti V, Robinson CV, Hutchinson WL, Fraser PE, Hawkins PN, Dobson CM, Radford SE, Blake CCF, Pepys MB: Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis. Nature 1997, 385:787-793
36. Liepnieks JJ, Ghetti B, Farlow M, Roses AD, Benson MD: Characterization of amyloid fibril-peptide in familial Alzheimer disease with APP 717 mutations. Biochem Biophys Res Commun 1993, 197:386-392
37. Citron M, Oltersdorf T, Haass C, McConlogue L, Hung AY, Seubert P, Vigo-Pelfrey C, Lieberburg I, Selkoe DJ: Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production. Nature 1992, 360:672-674
38. Tomia T, Maruyama K, Saido TC, Kume H, Shinozaki K, Tokuhiro S, Capell A, Walter J, Grünberg J, Haass C, Iwatsubo T, Obata K: The presenilin 2 mutation (N141l) linked to familial Alzheimer disease (Volga German families) increases the secretion of amyloid β protein ending at the 42nd (or 43rd) residue. Proc Natl Acad Sci USA 1997, 94:2025-2030
39. IOWA, associated with hypoalphalipoproteinemia and hereditary systemic amyloidosis. J Lipid Res 1992, 33:755-763